Overview
Development Candidates
Alliances
DEVELOPMENT CANDIDATES
Millennium is currently studying several investigational drugs for their potential in the treatment of inflammatory disorders. These include:
MLN0002
MLN3126
MLN1202
MLN3897 / 3701
MLN0415
MLN6095
Rigorous clinical trials will be necessary to determine the ultimate clinical benefits of these compounds.
© 2008 Millennium Pharmaceuticals, Inc.
Update Notice
|
Usage Terms
|
Privacy Policy